ENVB

Conviction 22HealthcareScan · Mon, Aug 10, 2026

ENVB$1.55+0.00%

ResistanceSupportVol 14

Vol MA14 141.05K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Enveric Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.enveric.com ↗

Price1.55

Change+0.00%

Gap-0.65%

Rel volume0.16×

Avg volume139.55K

Avg $ vol201.71K

SMA 201.43

SMA 501.51

SMA 2003.08

Price vs 50+2.73%

Price vs 200-49.61%

MA stackmixed

50/200 cross—

Supertrendup · 1.28

RSI (14)54

MACD hist0.04

MACD cross—

Stoch %K / %D60 / 61

ADX (14)21

+DI / −DI25 / 14

RSI divergence—

MACD divergence—

ATR %+8.58%

ADR %7.97%

52w high10.33

52w low0.5820

From 52w high-85.00%

Above 52w low+166.32%

New 52w highNo

SqueezeOff

Bollinger width37.75%

%B0.73

Donchian pos60.00%

Donchian high1.75

Donchian low1.25

AVWAP (52w high)4.86

vs AVWAP high-68.13%

AVWAP (52w low)4.66

vs AVWAP low-66.72%

OBV trendFlat

Chaikin MF (20)0.13

Today vs 20d0.16×

Avg vol (14d)141.05K

Avg vol (20d)139.55K

Avg $ vol (20d)201.71K

Market cap5.71M

RS 3m (vs SPY)-56.80%

RS 6m (vs SPY)-55.18%

RS line new highNo

Trend template3/8

Technical rank31.0

1 week-3.13%

1 month+14.81%

3 months-45.61%

6 months-34.60%

1 year+39.64%

YTD-57.77%

P/E-0.65

P/B1.13

P/S—

P/FCF-0.70

EPS-36.24

Div yield—

ROE-173.33%

ROA-158.87%

Debt/Eq0.00

Current11.67

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth8.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.87M

Revenue8.48M

Net income-1.63M

Gross profit1.89M

Free cash flow-8.15M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.68M

Employees6

ListedThu, Aug 24, 1995

Free float1.24M

Float %89.5%

Short interest18.51K

Days to cover0.2d

Short volume60.4%

Squeeze score18 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank31.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.66

Support1.25

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENVB

All disclosures →

No recent disclosed trades by Congress in ENVB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENVB · 8 buys

Insider	Side	Shares	Value	Traded	Filed
DeWitt Sheila Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Coveney Kevin Michael Chief Financial Officer · Common Stock · 2026-06-01	Grant	133.33K	$0	2026-06-01	2026-06-03
Facchini Peter J. Chief Innovation Officer · Common Stock · 2026-06-01	Grant	25K	$0	2026-06-01	2026-06-03
WEBB MICHAEL D Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Tucker Joseph Edward Chief Executive Officer · Common Stock · 2026-06-01	Grant	201.12K	$0	2026-06-01	2026-06-03
Schabacker Marcus Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
Kegler George A. Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03
PASQUALONE FRANK Director · Common Stock · 2026-06-01	Grant	18.52K	$0	2026-06-01	2026-06-03

SEC filings

EDGAR filings in ENVB · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.